Biopharma history

In 1920, with the opening of epidemiological, microbiological, parasitological and sanitary-hygienic departments, it was renamed to the "Sanitary and Bacteriological Institute."

Two years after its founding in 1931, the company opened its first manufacturing facility in a renovated automobile showroom in Glenview, Illinois, USA. There, six employees turned out the complete line of five intravenous solutions in glass containers.

In 1955, the manufacturing expanded to 12 bacterial drugs.

In 2005, the company implemented the technology of the virus inactivation by the solvent/detergent method in the production of immunoglobulins.

Biopharma MEA, was founded in 2007, by Sh.

In the case of Roche, before 2009 it already owned 50% of Genentech but in a silent leave-it-alone sort of partnership.

In 2012, Horizon Capital and FMO invested in Biopharma for building a new biopharmaceutical production factory equipped with a quality control laboratory.

In 2014, the first phase of the Biopharmaceutical Research and Manufacturing Complex was launched in Bila Tserkva.

The official opening of the Biopharmaceutical NSC "Biopharma" took place on June 16, 2015.

Awarded the ISPE's 2016 Facility of the Year (FOYA) Category Award for Operational Excellence (Halle, Germany facility expansion).

In October 2017, after the construction of a new building, the installation of technical equipment was started.

Dexcom G6 gets FDA nodMarch 28, 2018Siponimod trial ‘first’ to show delayed disability in secondary progressive MSMarch 22, 2018FDA approves new option in Hodgkin lymphoma treatmentMarch 20, 2018FDA approves subcutaneous immunoglobulin treatment for CIDPMarch 20, 2018

2019 — opening and launch of the first plasma fractionation plant in Ukraine which became the first such plant in Ukraine that can process up to one million liters of plasma per year.